Dr. Mikhail V. Blagosklonny, Editor-in-Chief of Cell Cycle, joins the Roswell Park Cancer Institute

As of April 15, 2009, Mikhail (Misha) Blagosklonny, MD, PhD (pictured right), has been appointed Member/Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Cancer Institute, Buffalo, NY. Dr. Blagosklonny is the author of over 170 research articles, reviews and book chapters. He is the Editor-in-Chief of Cell Cycle and also serves as an Associate Editor for Cancer Biology & Therapy, Autophagy, Cancer Research, Cell Death and Differentiation, International Journal of Cancer, The American Journal of Pathology and  PLOS ONE. His research interests range from molecular and cellular biology to clinical investigations and include signal transduction, cell cycle, cellular senescence, and anticancer therapeutics with an emphasis on translation of basic science into new anticancer strategies. He extended the study of signal transduction pathways from cancer to aging, revealing potential targets for slowing down aging and age-related diseases.  “Misha is a pre-eminent researcher, who developed unique concepts on cancer biology and therapy ,” according to Andrei V. Gudkov, Senior Vice-President of Basic Science at Roswell Park and Chairman of the Department of Cell Stress Biology (pictured left). “The presence of Misha will facilitate the development of new anti-cancer strategies and methods of cancer therapy and prevention. Here at Roswell, we are very enthusiastic about his recruitment. We share numerous ideas and approaches, including protection of normal cells from radio- and chemotherapy, selective combinations of anticancer drugs, tissue-specific therapy (anti-tissue therapy) of cancer, and prevention of cancer by slowing down organismal aging”.

Cell Cycle will reconsider papers rejected by Science, Nature and Cell and others.

Cell Cycle recognizes that excellent papers may have been erroneously rejected by other journals. We will reconsider papers that have been rejected by Nature, Science, Nature Medicine, Nature Cell Biology, Cell, Cancer Cell, Cell Metabolism, Developmental Cell, NEJM, Lancet, Genes & Development and some other journals in the original format of those journals, thus saving the authors effort and time. The authors are encouraged to enclose the reviewers' and/or editorial comments from the above mentioned journals. This will certainly expedite the evaluation of the article and it is possible the article might be accepted based on its previous review. This will allow the urgent and competitive research to be published in a timely manner. You may submit your paper online. Following submission, please contact Yelena Boryskina, Assitant to the Editor-in-Chief, with the manuscript number and copies of the previous reviews. If you have questions, you may also contact Dr. Blagosklonny, the Editor-in-Chief, directly.